BridgeBio Pharma (BBIO) PT Raised to $29 at Raymond James, 'Marked AHV Gain Shown in PROPEL 2 Cohort 5'
Tweet Send to a Friend
(Updated - March 6, 2023 9:21 AM EST)
Raymond James analyst Dane Leone raised the price target on BridgeBio ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst Dane Leone raised the price target on BridgeBio ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
